“Made for you” does not answer the approval question.
The September 26, 2026 record draws a firm distinction: FDA approval does not extend to compounded preparations.
FDA does not review how well a compounded drug works, its quality, or its safety before it reaches the market.
FDA is short for Food and Drug Administration. Ask what makes this preparation fit the person who will receive it.
An approved product may fail to meet a person’s medical need; FDA recognises that compounding can have a role in that situation.
FDA gives the examples of a person unable to swallow a tablet, or someone who is allergic to a dye in a medicine.
That is a reason to ask why a particular change matters for this patient. It is not a reason to assume every pharmacy-made preparation can replace a brand medicine.
The national shortage and a local empty shelf differ.
A national shortage listing can affect the rules for making copies; a nearby pharmacy running out is a different matter.
The semaglutide injection shortage was declared resolved by FDA on February 21, 2025.
The rule checked September 26, 2026 bars pharmacists and doctors from routinely making copies, or making excessive amounts, of drugs already sold on the market.
A change for one identified patient can take a medicine outside this rule about copies. The prescriber, the person writing the prescription, must decide what important medical difference that change will make for this patient.
This exception deals only with the rule about copies.
Ask the prescriber and pharmacy to explain how the preparation meets the other rules too.
A lower price on its own does not establish that patient-specific difference.
Ask about a change, not just a label.
In FDA’s April 2026 example, adding vitamin B12 to a semaglutide injection can still count as making a copy. The main medicine ingredient matches an available product. The strength is similar, and both are injections.
Adding the vitamin alone does not get around that rule. The prescriber must record why a change makes a meaningful difference for the individual patient.
A vitamin added to the name is not, by itself, an explanation of why the preparation fits the patient.
- What does this change solve for my health, and who has decided that?
- Which pharmacy will prepare it?
- How does the prescriber explain the basis for this preparation?